[Note] Domestic flight fuel surcharge is reduced, a ticket is reduced by up to 60 yuan

Author:Yanji News Network Time:2022.08.08

The reporter learned from Ctrip, Flying Pig, Qunar and other air ticket intermediary websites that these platforms have received news from a number of domestic airlines to adjust the standards for domestic routes to collect fuel surcharges on the domestic routes on August 5.

The reporter found that airlines such as Oriental Airlines and Shanghai Airlines will adjust the standard for domestic flight fuel surcharges from 00:00 on August 5 (ticket date). Each passenger charges 80 yuan fuel surcharge, and each passenger of more than 800 kilometers is charged 140 yuan, which is reduced by 20 yuan and 60 yuan compared to the adjustment before adjustment.

This is also the first time that domestic airlines have restored the fuel surcharge in February this year. According to the adjustment of this fuel surcharge, in the case of excluding domestic aircraft exemption, adult ticket domestic travel costs will start from 130 yuan, and the construction fee of airport airports above 800 kilometers plus fuel fee will reach 190 yuan Essence

Since the airline recovered domestic route fuel surcharge in February this year, in just half a year, the fuel surcharge collection standard has been raised five consecutive times, from 10 yuan below the initial 800 kilometers (inclusive), and 20 yuan above 800 kilometers to 100 to 100 And 200 yuan. For passengers, the reduction of fuel surcharges can directly reduce the cost of travel. Passengers have more ways to travel, while stimulating the increased willingness to travel.

- END -

Millennium ancient lotus, thousands of lotus ... Treasure Lotus first in the Wuhan Botanical Garden Lotus Exhibition

Jimu Journalist Chen Xi LihuiCorrespondent Chen ChangliAfter the lotus is blooming...

Yasheng Pharmaceutical-B: Original 1 new medicine Nishik was allowed to conduct clinical trials in Canada

On July 22, 2022, Yasheng Pharmaceutical-B (06855.HK) announced that the company's 1-type new medicine Nishiki (O'rabatinib) has recently obtained the clinical trial of the Canadian Ministry of Health...